Table 1 Demographic and clinical information of patients with pseudoexfoliative glaucoma (PEG), patients with pseudoexfoliation syndrome (PEX), and the controls
PEG (n = 239) | PEX (n = 240) | Control (n = 240) | P | ||
|---|---|---|---|---|---|
Age (years), | mean ± SD | 71.0 ± 7.9 | 70.2 ± 6.8 | 69.7 ± 8.5 | .178 |
median (Q1-Q3) | 72 (66–77) | 69 (66–75) | 69 (65–76) | ||
Gender | |||||
male/female, n | 136/103 | 122/118 | 116/124 | .155 | |
male % | 56.9 | 50.8 | 48.3 | ||
Systemic hypertension, n (%) | 113 (47.3) | 113 (47.1) | 118 (49.2) | .881 | |
Diabetes, n (%) | 57 (23.8) | 63 (26.3) | 61 (25.4) | .828 | |
Cardiovascular disease, n (%) | 62 (25.9) | 70 (29.2) | 73 (30.4) | .535 | |
Smokers, n (%) | 33 (13.8) | 32 (13.3) | 36 (15.0) | .864 | |
Clinical visual characteristics | |||||
Intraocular pressure (IOP, mmHg), | mean ± SD | 21.7 ± 5.3 | 20.1 ± 5.4 | 19.7 ± 5.6 | < .001 |
median (Q1-Q3) | 21.0 (18.0 – 24.0) | 19.0 (16.0 – 23.0) | 19.0 (16.0 – 23.0) | ||
Visual Field Score (VFS), | mean ± SD | 2.61 ± 0.80 | 1.00 ± 0.00 | 1.00 ± 0.00 | < .001 |
median (Q1-Q3) | 2.0 (2.0 – 3.0) | 1.0 (1.0 – 1.0) | 1.0 (1.0 – 1.0) | ||
Mean deviation (MD), | mean ± SD | -7.08 ± 6.48 | -1.23 ± 2.29 | -0.98 ± 0.68 | < .001 |
median (Q1-Q3) | -4.00 (-8.2 – -2.8) | -0.90 (-1.5 – -0.5) | -0.80 (-1.4 – -0.5) | ||
Pattern standard deviation (PSD), | mean ± SD | 4.93 ± 2.98 | 1.52 ± 0.72 | 1.45 ± 0.25 | < .001 |
median (Q1-Q3) | 4.10 (2.8 – 6.1) | 1.40 (1.3 – 1.6) | 1.50 (1.2 – 1.6) | ||